Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department

We compared ID Now™ and Hologic® Panther Aptima™ for the detection of SARS-COV-2. ID Now™ showed a positive and negative percent agreement of 86.9% and 99.7% respectively. This facilitates faster clinical decision-making, along with the rapid implementation of infection control measures, and improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Bousquet, Aurore, Larréché, Sébastien, Bigaillon, Christine, Woloch, Alexandre, Thomas, Léa, Conan, Pierre Louis, Mérens, Audrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188679/
https://www.ncbi.nlm.nih.gov/pubmed/35843113
http://dx.doi.org/10.1016/j.diagmicrobio.2022.115742
_version_ 1784725421541031936
author Bousquet, Aurore
Larréché, Sébastien
Bigaillon, Christine
Woloch, Alexandre
Thomas, Léa
Conan, Pierre Louis
Mérens, Audrey
author_facet Bousquet, Aurore
Larréché, Sébastien
Bigaillon, Christine
Woloch, Alexandre
Thomas, Léa
Conan, Pierre Louis
Mérens, Audrey
author_sort Bousquet, Aurore
collection PubMed
description We compared ID Now™ and Hologic® Panther Aptima™ for the detection of SARS-COV-2. ID Now™ showed a positive and negative percent agreement of 86.9% and 99.7% respectively. This facilitates faster clinical decision-making, along with the rapid implementation of infection control measures, and improvement of patient flow in the emergency department toward inpatient wards.
format Online
Article
Text
id pubmed-9188679
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-91886792022-06-13 Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department Bousquet, Aurore Larréché, Sébastien Bigaillon, Christine Woloch, Alexandre Thomas, Léa Conan, Pierre Louis Mérens, Audrey Diagn Microbiol Infect Dis Article We compared ID Now™ and Hologic® Panther Aptima™ for the detection of SARS-COV-2. ID Now™ showed a positive and negative percent agreement of 86.9% and 99.7% respectively. This facilitates faster clinical decision-making, along with the rapid implementation of infection control measures, and improvement of patient flow in the emergency department toward inpatient wards. Elsevier Inc. 2022-09 2022-06-12 /pmc/articles/PMC9188679/ /pubmed/35843113 http://dx.doi.org/10.1016/j.diagmicrobio.2022.115742 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bousquet, Aurore
Larréché, Sébastien
Bigaillon, Christine
Woloch, Alexandre
Thomas, Léa
Conan, Pierre Louis
Mérens, Audrey
Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
title Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
title_full Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
title_fullStr Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
title_full_unstemmed Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
title_short Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
title_sort abbott® id now™ covid-19 rapid molecular assay versus hologic® panther aptima™ sars-cov-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188679/
https://www.ncbi.nlm.nih.gov/pubmed/35843113
http://dx.doi.org/10.1016/j.diagmicrobio.2022.115742
work_keys_str_mv AT bousquetaurore abbottidnowcovid19rapidmolecularassayversushologicpantheraptimasarscov2assayinnasopharyngealspecimensresultsfrom1yearretrospectivestudyinanemergencydepartment
AT larrechesebastien abbottidnowcovid19rapidmolecularassayversushologicpantheraptimasarscov2assayinnasopharyngealspecimensresultsfrom1yearretrospectivestudyinanemergencydepartment
AT bigaillonchristine abbottidnowcovid19rapidmolecularassayversushologicpantheraptimasarscov2assayinnasopharyngealspecimensresultsfrom1yearretrospectivestudyinanemergencydepartment
AT wolochalexandre abbottidnowcovid19rapidmolecularassayversushologicpantheraptimasarscov2assayinnasopharyngealspecimensresultsfrom1yearretrospectivestudyinanemergencydepartment
AT thomaslea abbottidnowcovid19rapidmolecularassayversushologicpantheraptimasarscov2assayinnasopharyngealspecimensresultsfrom1yearretrospectivestudyinanemergencydepartment
AT conanpierrelouis abbottidnowcovid19rapidmolecularassayversushologicpantheraptimasarscov2assayinnasopharyngealspecimensresultsfrom1yearretrospectivestudyinanemergencydepartment
AT merensaudrey abbottidnowcovid19rapidmolecularassayversushologicpantheraptimasarscov2assayinnasopharyngealspecimensresultsfrom1yearretrospectivestudyinanemergencydepartment

Ejemplares similares